UPK3B
Uroplakin-3b
Also known as: FLJ32198, MGC10902, p35, UPIIIb, UPK3B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BT76
- Gene
- UPK3B
- Ensembl
- ENSG00000243566
- Chromosome
- 7
- Canonical length
- 320 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
UPK3B is a minor component of the apical plaques of mammalian urothelium that binds and dimerizes with uroplakin-1b (UPK1B; MIM 602380), one of the major conserved urothelium membrane proteins. The other major conserved integral membrane proteins of urothelial plaques are UPK1A (MIM 611557), UPK2 (MIM 611558), and UPK3A (MIM 611559) (Deng et al., 2002 [PubMed 12446744]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
320 residues, UniProt reviewed canonical sequence.
>Q9BT76|UPK3B
1 MGLPWGQPHL GLQMLLLALN CLRPSLSLGE WGSWMDASSQ TQGAGGPAGV IGPWAPAPLR
61 LGEAAPGTPT PVSVAHLLSP VATELVPYTP QITAWDLEGK VTATTFSLEQ PRCVFDGLAS
121 ASDTVWLVVA FSNASRGFQN PETLADIPAS PQLLTDGHYM TLPLSPDQLP CGDPMAGSGG
181 APVLRVGHDH GCHQQPFCNA PLPGPGPYRE DPRIHRHLAR AAKWQHDRHY LHPLFSGRPP
241 TLGLLGSLYH ALLQPVVAGG GPGAAADRLL HGQALHDPPH PTQRGRHTAG GLQAWPGPPP
301 QPQPLAWPLC MGLGEMGRWELocalizationUniProt · AlphaFold · HPA
Whether an antibody against UPK3B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 113 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 113 nTPM
- esophagus: 64 nTPM
- lung: 48 nTPM
- urinary bladder: 34 nTPM
- vagina: 11 nTPM
- heart muscle: 10 nTPM
Single-cell type
- mesothelial cells: 30 nCPM
- esophageal apical cells: 28 nCPM
- alveolar cells type 1: 22 nCPM
- papillary tip epithelial cells: 14 nCPM
- urothelial cells: 8.2 nCPM
- epicardial cells: 4.5 nCPM
Immune cell
- neutrophil: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- choroid plexus: 2.1 nTPM
- thalamus: 1.4 nTPM
- basal ganglia: 1.1 nTPM
- cerebral cortex: 1 nTPM
- hypothalamus: 0.7 nTPM
- midbrain: 0.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.22
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.19
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UPK3B as an antibody target. Whether an autoantibody or antibody against UPK3B could matter depends on whether native UPK3B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UPK3B is annotated at the cell surface, where native UPK3B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label UPK3B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...